Using the Anderson model of health behavior[14,15] framework, the primary objective of MOSAIc is to identify patient, physician, and health care environment factors that influence insulin progression among patients with T2DM and to quantify the relationships between these factors and long-term clinical outcomes. This evidence concerns the gene INS and type 2 diabetes mellitus.